General MedicationsORALStandard
MOEXIPRIL HYDROCHLORIDE
MOEXIPRIL HYDROCHLORIDE
Standard Dose
7.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview MOEXIPRIL HYDROCHLORIDE is listed in Drugs@FDA under application 090416 (ANDA).
Marketing status: Prescription Active ingredient MOEXIPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - 7.5MG Sponsor GLENMARK PHARMS LTD Submission history Latest submission status date: 2015-03-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview MOEXIPRIL HYDROCHLORIDE is listed in Drugs@FDA under application 090416 (ANDA). Marketing status: Prescription Active ingredient MOEXIPRIL HYDROCHLORIDE Form and strength TABLET;ORAL - 7.5MG Sponsor GLENMARK PHARMS LTD Submission history Latest submission status date: 2015-03-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.